Sign in
Not yet recruitingNo phase

Function-Friendly Semi-Fowler Positioning for Coronary Angiography and PCI

Key facts

Who runs it
Shanghai Zhongshan Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
10 people, planned
Starts
25 Nov 2026
Expected to end
Nov 2028
Type of study
Interventional
Treatments tested
  • Function-Friendly Semi-Fowler Positioning
Record updated
18 November 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (20)Hide the full registry criteria

Who can take part

  • Age 18 to 75 years
  • Clinically stable and scheduled for elective coronary angiography (CAG) or planned simple percutaneous coronary intervention (PCI), with no ongoing resting ischemia
  • Meets clinical indications for coronary angiography or intervention, with ischemic evidence consistent with coronary artery disease based on symptoms, ECG, or noninvasive imaging
  • Planned radial access; the operator expects the procedure can be performed using standard catheters and devices
  • Able to tolerate a monitored 60-degree semi-Fowler position for at least 10 minutes before the procedure
  • Body size, weight, shoulder width, and range of motion are within equipment and support-system limits, and the participant can be secured using the manufacturer-approved fixation system
  • Able to understand the study and provide written informed consent

Who cannot take part

  • Participation in another clinical trial or research study within 2 months before screening
  • Known contraindication to local anesthetic or history of severe contrast-media allergy
  • Neurologic or psychiatric disease or language impairment that prevents effective communication or cooperation
  • Uncontrolled hypertension (screening systolic blood pressure >180 mmHg or diastolic blood pressure >100 mmHg) or baseline systolic blood pressure <100 mmHg
  • Acute coronary syndrome, ongoing ischemia, hemodynamic instability, cardiogenic shock, or need for emergency CAG/PCI
  • Known or highly suspected high-risk left main disease, chronic total occlusion, complex bifurcation disease, severe calcification, or other anatomy expected to require complex PCI
  • Any other condition for which the investigator considers participation unsafe
  • Decompensated heart failure, left ventricular ejection fraction <30%, inability to maintain oxygenation at rest, or estimated glomerular filtration rate <30 mL/min/1.73 m\^2
  • Platelet count <50 × 10\^9/L or coagulation results outside the institution usual acceptable range
  • Pregnant or breastfeeding, or the participant or spouse plans pregnancy within the next 6 months
  • Serious comorbidity with expected survival less than 6 months
  • Back pain, stiffness, limited mobility, or injury preventing tolerance of transition from supine to the study position
  • Inability to secure the torso reliably, inability to complete the pre-procedure positioning-tolerance test, or investigator judgment that emergency return to supine may be restricted

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Coronary disease

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will assess whether planned coronary angiography (CAG), and simple percutaneous coronary intervention (PCI) when needed, can be completed safely and technically while participants are in a semi-sitting position with the head of the procedure table raised to 60 degrees. Ten clinically stable adults scheduled for an elective procedure are planned. The first stage will include participants undergoing CAG. After a safety review, the study may include participants expected to need only simple PCI. Heart rhythm, blood pressure, and blood oxygen will be monitored continuously. If predefined safety criteria occur, staff will lower the table or return the participant to a flat position and provide usual clinical care. Researchers will describe procedure completion, image quality, radiation exposure, contrast use, tolerance of the position, and safety events through 3 days after the procedure. This exploratory study is not designed to establish treatment efficacy.

The group in the trial

  • Function-Friendly Semi-Fowler PositioningTreatment being tested

    All participants receive the same positioning intervention during elective transradial CAG and, if clinically indicated, simple PCI. The procedure table is raised to a default head elevation of 60 degrees, with continuous ECG, blood pressure, and oxygen saturation monitoring. If predefined safety concerns occur, the table angle is lowered or the participant is returned to 0-degree supine and usual clinical care is provided.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pilot Study on the Feasibility and Safety of Function-Friendly Semi-Fowler Positioning in Coronary Angiography and Percutaneous Coronary Intervention
Criteria questions
Built from NCT07944716, who can take part
Record updated
18 November 2026